Pfizer - 51 Year Dividend History | PFE

Historical dividend payout and yield for Pfizer (PFE) since 1974. The current TTM dividend payout for Pfizer (PFE) as of June 09, 2025 is $1.72. The current dividend yield for Pfizer as of June 09, 2025 is 7.37%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $132.753B $63.627B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $729.643B 55.95
Johnson & Johnson (JNJ) United States $373.014B 15.43
AbbVie (ABBV) United States $335.316B 18.48
Roche Holding AG (RHHBY) Switzerland $260.602B 0.00
Novartis AG (NVS) Switzerland $249.308B 14.24
Merck (MRK) United States $198.296B 10.14
Sanofi (SNY) France $123.776B 12.19
Bayer (BAYRY) Germany $29.826B 6.07
Innoviva (INVA) United States $1.355B 14.20
Novo Nordisk (NVO) Denmark $0.000B 22.08